Global BCG Vaccine for Intradermal Injection Market Growth 2026-2032
The global BCG Vaccine for Intradermal Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for BCG Vaccine for Intradermal Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for BCG Vaccine for Intradermal Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for BCG Vaccine for Intradermal Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key BCG Vaccine for Intradermal Injection players cover Merck, Sanofi Pasteur, Japan BCG Lab, Shanghai Institute of Biological Products, Serum Institute of India, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?BCG Vaccine for Intradermal Injection Industry Forecast? looks at past sales and reviews total world BCG Vaccine for Intradermal Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected BCG Vaccine for Intradermal Injection sales for 2026 through 2032. With BCG Vaccine for Intradermal Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccine for Intradermal Injection industry.
This Insight Report provides a comprehensive analysis of the global BCG Vaccine for Intradermal Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccine for Intradermal Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global BCG Vaccine for Intradermal Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccine for Intradermal Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccine for Intradermal Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine for Intradermal Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for BCG Vaccine for Intradermal Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for BCG Vaccine for Intradermal Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for BCG Vaccine for Intradermal Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key BCG Vaccine for Intradermal Injection players cover Merck, Sanofi Pasteur, Japan BCG Lab, Shanghai Institute of Biological Products, Serum Institute of India, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?BCG Vaccine for Intradermal Injection Industry Forecast? looks at past sales and reviews total world BCG Vaccine for Intradermal Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected BCG Vaccine for Intradermal Injection sales for 2026 through 2032. With BCG Vaccine for Intradermal Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccine for Intradermal Injection industry.
This Insight Report provides a comprehensive analysis of the global BCG Vaccine for Intradermal Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccine for Intradermal Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global BCG Vaccine for Intradermal Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccine for Intradermal Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccine for Intradermal Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine for Intradermal Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- BCG for Immunization
- BCG for Therapy
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Sanofi Pasteur
- Japan BCG Lab
- Shanghai Institute of Biological Products
- Serum Institute of India
- Intervax
- GSBPL
- What is the 10-year outlook for the global BCG Vaccine for Intradermal Injection market?
- What factors are driving BCG Vaccine for Intradermal Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do BCG Vaccine for Intradermal Injection market opportunities vary by end market size?
- How does BCG Vaccine for Intradermal Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global BCG Vaccine for Intradermal Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for BCG Vaccine for Intradermal Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for BCG Vaccine for Intradermal Injection by Country/Region, 2021, 2025 & 2032
2.2 BCG Vaccine for Intradermal Injection Segment by Type
2.2.1 BCG for Immunization
2.2.2 BCG for Therapy
2.2.3 BCG Vaccine for Intradermal Injection Sales by Type
2.2.3.1 Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global BCG Vaccine for Intradermal Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global BCG Vaccine for Intradermal Injection Sale Price by Type (2021-2026)
2.3 BCG Vaccine for Intradermal Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 BCG Vaccine for Intradermal Injection Sales by Application
2.3.4.1 Global BCG Vaccine for Intradermal Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global BCG Vaccine for Intradermal Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global BCG Vaccine for Intradermal Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global BCG Vaccine for Intradermal Injection Breakdown Data by Company
3.1.1 Global BCG Vaccine for Intradermal Injection Annual Sales by Company (2021-2026)
3.1.2 Global BCG Vaccine for Intradermal Injection Sales Market Share by Company (2021-2026)
3.2 Global BCG Vaccine for Intradermal Injection Annual Revenue by Company (2021-2026)
3.2.1 Global BCG Vaccine for Intradermal Injection Revenue by Company (2021-2026)
3.2.2 Global BCG Vaccine for Intradermal Injection Revenue Market Share by Company (2021-2026)
3.3 Global BCG Vaccine for Intradermal Injection Sale Price by Company
3.4 Key Manufacturers BCG Vaccine for Intradermal Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG Vaccine for Intradermal Injection Product Location Distribution
3.4.2 Players BCG Vaccine for Intradermal Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BCG VACCINE FOR INTRADERMAL INJECTION BY GEOGRAPHIC REGION
4.1 World Historic BCG Vaccine for Intradermal Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global BCG Vaccine for Intradermal Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global BCG Vaccine for Intradermal Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic BCG Vaccine for Intradermal Injection Market Size by Country/Region (2021-2026)
4.2.1 Global BCG Vaccine for Intradermal Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global BCG Vaccine for Intradermal Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas BCG Vaccine for Intradermal Injection Sales Growth
4.4 APAC BCG Vaccine for Intradermal Injection Sales Growth
4.5 Europe BCG Vaccine for Intradermal Injection Sales Growth
4.6 Middle East & Africa BCG Vaccine for Intradermal Injection Sales Growth
5 AMERICAS
5.1 Americas BCG Vaccine for Intradermal Injection Sales by Country
5.1.1 Americas BCG Vaccine for Intradermal Injection Sales by Country (2021-2026)
5.1.2 Americas BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026)
5.2 Americas BCG Vaccine for Intradermal Injection Sales by Type (2021-2026)
5.3 Americas BCG Vaccine for Intradermal Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG Vaccine for Intradermal Injection Sales by Region
6.1.1 APAC BCG Vaccine for Intradermal Injection Sales by Region (2021-2026)
6.1.2 APAC BCG Vaccine for Intradermal Injection Revenue by Region (2021-2026)
6.2 APAC BCG Vaccine for Intradermal Injection Sales by Type (2021-2026)
6.3 APAC BCG Vaccine for Intradermal Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe BCG Vaccine for Intradermal Injection by Country
7.1.1 Europe BCG Vaccine for Intradermal Injection Sales by Country (2021-2026)
7.1.2 Europe BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026)
7.2 Europe BCG Vaccine for Intradermal Injection Sales by Type (2021-2026)
7.3 Europe BCG Vaccine for Intradermal Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa BCG Vaccine for Intradermal Injection by Country
8.1.1 Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Type (2021-2026)
8.3 Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG Vaccine for Intradermal Injection
10.3 Manufacturing Process Analysis of BCG Vaccine for Intradermal Injection
10.4 Industry Chain Structure of BCG Vaccine for Intradermal Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG Vaccine for Intradermal Injection Distributors
11.3 BCG Vaccine for Intradermal Injection Customer
12 WORLD FORECAST REVIEW FOR BCG VACCINE FOR INTRADERMAL INJECTION BY GEOGRAPHIC REGION
12.1 Global BCG Vaccine for Intradermal Injection Market Size Forecast by Region
12.1.1 Global BCG Vaccine for Intradermal Injection Forecast by Region (2027-2032)
12.1.2 Global BCG Vaccine for Intradermal Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global BCG Vaccine for Intradermal Injection Forecast by Type (2027-2032)
12.7 Global BCG Vaccine for Intradermal Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.1.3 Merck BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.2.3 Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Lab
13.3.1 Japan BCG Lab Company Information
13.3.2 Japan BCG Lab BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.3.3 Japan BCG Lab BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Japan BCG Lab Main Business Overview
13.3.5 Japan BCG Lab Latest Developments
13.4 Shanghai Institute of Biological Products
13.4.1 Shanghai Institute of Biological Products Company Information
13.4.2 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.4.3 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Institute of Biological Products Main Business Overview
13.4.5 Shanghai Institute of Biological Products Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.5.3 Serum Institute of India BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Intervax
13.6.1 Intervax Company Information
13.6.2 Intervax BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.6.3 Intervax BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Intervax Main Business Overview
13.6.5 Intervax Latest Developments
13.7 GSBPL
13.7.1 GSBPL Company Information
13.7.2 GSBPL BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.7.3 GSBPL BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GSBPL Main Business Overview
13.7.5 GSBPL Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global BCG Vaccine for Intradermal Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for BCG Vaccine for Intradermal Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for BCG Vaccine for Intradermal Injection by Country/Region, 2021, 2025 & 2032
2.2 BCG Vaccine for Intradermal Injection Segment by Type
2.2.1 BCG for Immunization
2.2.2 BCG for Therapy
2.2.3 BCG Vaccine for Intradermal Injection Sales by Type
2.2.3.1 Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global BCG Vaccine for Intradermal Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global BCG Vaccine for Intradermal Injection Sale Price by Type (2021-2026)
2.3 BCG Vaccine for Intradermal Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 BCG Vaccine for Intradermal Injection Sales by Application
2.3.4.1 Global BCG Vaccine for Intradermal Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global BCG Vaccine for Intradermal Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global BCG Vaccine for Intradermal Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global BCG Vaccine for Intradermal Injection Breakdown Data by Company
3.1.1 Global BCG Vaccine for Intradermal Injection Annual Sales by Company (2021-2026)
3.1.2 Global BCG Vaccine for Intradermal Injection Sales Market Share by Company (2021-2026)
3.2 Global BCG Vaccine for Intradermal Injection Annual Revenue by Company (2021-2026)
3.2.1 Global BCG Vaccine for Intradermal Injection Revenue by Company (2021-2026)
3.2.2 Global BCG Vaccine for Intradermal Injection Revenue Market Share by Company (2021-2026)
3.3 Global BCG Vaccine for Intradermal Injection Sale Price by Company
3.4 Key Manufacturers BCG Vaccine for Intradermal Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG Vaccine for Intradermal Injection Product Location Distribution
3.4.2 Players BCG Vaccine for Intradermal Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BCG VACCINE FOR INTRADERMAL INJECTION BY GEOGRAPHIC REGION
4.1 World Historic BCG Vaccine for Intradermal Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global BCG Vaccine for Intradermal Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global BCG Vaccine for Intradermal Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic BCG Vaccine for Intradermal Injection Market Size by Country/Region (2021-2026)
4.2.1 Global BCG Vaccine for Intradermal Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global BCG Vaccine for Intradermal Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas BCG Vaccine for Intradermal Injection Sales Growth
4.4 APAC BCG Vaccine for Intradermal Injection Sales Growth
4.5 Europe BCG Vaccine for Intradermal Injection Sales Growth
4.6 Middle East & Africa BCG Vaccine for Intradermal Injection Sales Growth
5 AMERICAS
5.1 Americas BCG Vaccine for Intradermal Injection Sales by Country
5.1.1 Americas BCG Vaccine for Intradermal Injection Sales by Country (2021-2026)
5.1.2 Americas BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026)
5.2 Americas BCG Vaccine for Intradermal Injection Sales by Type (2021-2026)
5.3 Americas BCG Vaccine for Intradermal Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG Vaccine for Intradermal Injection Sales by Region
6.1.1 APAC BCG Vaccine for Intradermal Injection Sales by Region (2021-2026)
6.1.2 APAC BCG Vaccine for Intradermal Injection Revenue by Region (2021-2026)
6.2 APAC BCG Vaccine for Intradermal Injection Sales by Type (2021-2026)
6.3 APAC BCG Vaccine for Intradermal Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe BCG Vaccine for Intradermal Injection by Country
7.1.1 Europe BCG Vaccine for Intradermal Injection Sales by Country (2021-2026)
7.1.2 Europe BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026)
7.2 Europe BCG Vaccine for Intradermal Injection Sales by Type (2021-2026)
7.3 Europe BCG Vaccine for Intradermal Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa BCG Vaccine for Intradermal Injection by Country
8.1.1 Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Type (2021-2026)
8.3 Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG Vaccine for Intradermal Injection
10.3 Manufacturing Process Analysis of BCG Vaccine for Intradermal Injection
10.4 Industry Chain Structure of BCG Vaccine for Intradermal Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG Vaccine for Intradermal Injection Distributors
11.3 BCG Vaccine for Intradermal Injection Customer
12 WORLD FORECAST REVIEW FOR BCG VACCINE FOR INTRADERMAL INJECTION BY GEOGRAPHIC REGION
12.1 Global BCG Vaccine for Intradermal Injection Market Size Forecast by Region
12.1.1 Global BCG Vaccine for Intradermal Injection Forecast by Region (2027-2032)
12.1.2 Global BCG Vaccine for Intradermal Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global BCG Vaccine for Intradermal Injection Forecast by Type (2027-2032)
12.7 Global BCG Vaccine for Intradermal Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.1.3 Merck BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.2.3 Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Lab
13.3.1 Japan BCG Lab Company Information
13.3.2 Japan BCG Lab BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.3.3 Japan BCG Lab BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Japan BCG Lab Main Business Overview
13.3.5 Japan BCG Lab Latest Developments
13.4 Shanghai Institute of Biological Products
13.4.1 Shanghai Institute of Biological Products Company Information
13.4.2 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.4.3 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Institute of Biological Products Main Business Overview
13.4.5 Shanghai Institute of Biological Products Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.5.3 Serum Institute of India BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Intervax
13.6.1 Intervax Company Information
13.6.2 Intervax BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.6.3 Intervax BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Intervax Main Business Overview
13.6.5 Intervax Latest Developments
13.7 GSBPL
13.7.1 GSBPL Company Information
13.7.2 GSBPL BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
13.7.3 GSBPL BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GSBPL Main Business Overview
13.7.5 GSBPL Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. BCG Vaccine for Intradermal Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. BCG Vaccine for Intradermal Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of BCG for Immunization
Table 4. Major Players of BCG for Therapy
Table 5. Global BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Table 7. Global BCG Vaccine for Intradermal Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2021-2026)
Table 9. Global BCG Vaccine for Intradermal Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global BCG Vaccine for Intradermal Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global BCG Vaccine for Intradermal Injection Sale Market Share by Application (2021-2026)
Table 12. Global BCG Vaccine for Intradermal Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application (2021-2026)
Table 14. Global BCG Vaccine for Intradermal Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global BCG Vaccine for Intradermal Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global BCG Vaccine for Intradermal Injection Sales Market Share by Company (2021-2026)
Table 17. Global BCG Vaccine for Intradermal Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Company (2021-2026)
Table 19. Global BCG Vaccine for Intradermal Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers BCG Vaccine for Intradermal Injection Producing Area Distribution and Sales Area
Table 21. Players BCG Vaccine for Intradermal Injection Products Offered
Table 22. BCG Vaccine for Intradermal Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global BCG Vaccine for Intradermal Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global BCG Vaccine for Intradermal Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global BCG Vaccine for Intradermal Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global BCG Vaccine for Intradermal Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global BCG Vaccine for Intradermal Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global BCG Vaccine for Intradermal Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas BCG Vaccine for Intradermal Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas BCG Vaccine for Intradermal Injection Sales Market Share by Country (2021-2026)
Table 35. Americas BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas BCG Vaccine for Intradermal Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC BCG Vaccine for Intradermal Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC BCG Vaccine for Intradermal Injection Sales Market Share by Region (2021-2026)
Table 40. APAC BCG Vaccine for Intradermal Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC BCG Vaccine for Intradermal Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe BCG Vaccine for Intradermal Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe BCG Vaccine for Intradermal Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of BCG Vaccine for Intradermal Injection
Table 52. Key Market Challenges & Risks of BCG Vaccine for Intradermal Injection
Table 53. Key Industry Trends of BCG Vaccine for Intradermal Injection
Table 54. BCG Vaccine for Intradermal Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. BCG Vaccine for Intradermal Injection Distributors List
Table 57. BCG Vaccine for Intradermal Injection Customer List
Table 58. Global BCG Vaccine for Intradermal Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global BCG Vaccine for Intradermal Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas BCG Vaccine for Intradermal Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas BCG Vaccine for Intradermal Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC BCG Vaccine for Intradermal Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC BCG Vaccine for Intradermal Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe BCG Vaccine for Intradermal Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe BCG Vaccine for Intradermal Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global BCG Vaccine for Intradermal Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global BCG Vaccine for Intradermal Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global BCG Vaccine for Intradermal Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global BCG Vaccine for Intradermal Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 74. Merck BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Sanofi Pasteur Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Pasteur BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 79. Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Sanofi Pasteur Main Business
Table 81. Sanofi Pasteur Latest Developments
Table 82. Japan BCG Lab Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Japan BCG Lab BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 84. Japan BCG Lab BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Japan BCG Lab Main Business
Table 86. Japan BCG Lab Latest Developments
Table 87. Shanghai Institute of Biological Products Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 89. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Shanghai Institute of Biological Products Main Business
Table 91. Shanghai Institute of Biological Products Latest Developments
Table 92. Serum Institute of India Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Serum Institute of India BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 94. Serum Institute of India BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Serum Institute of India Main Business
Table 96. Serum Institute of India Latest Developments
Table 97. Intervax Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Intervax BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 99. Intervax BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Intervax Main Business
Table 101. Intervax Latest Developments
Table 102. GSBPL Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. GSBPL BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 104. GSBPL BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. GSBPL Main Business
Table 106. GSBPL Latest Developments
Table 1. BCG Vaccine for Intradermal Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. BCG Vaccine for Intradermal Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of BCG for Immunization
Table 4. Major Players of BCG for Therapy
Table 5. Global BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Table 7. Global BCG Vaccine for Intradermal Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2021-2026)
Table 9. Global BCG Vaccine for Intradermal Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global BCG Vaccine for Intradermal Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global BCG Vaccine for Intradermal Injection Sale Market Share by Application (2021-2026)
Table 12. Global BCG Vaccine for Intradermal Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application (2021-2026)
Table 14. Global BCG Vaccine for Intradermal Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global BCG Vaccine for Intradermal Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global BCG Vaccine for Intradermal Injection Sales Market Share by Company (2021-2026)
Table 17. Global BCG Vaccine for Intradermal Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Company (2021-2026)
Table 19. Global BCG Vaccine for Intradermal Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers BCG Vaccine for Intradermal Injection Producing Area Distribution and Sales Area
Table 21. Players BCG Vaccine for Intradermal Injection Products Offered
Table 22. BCG Vaccine for Intradermal Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global BCG Vaccine for Intradermal Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global BCG Vaccine for Intradermal Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global BCG Vaccine for Intradermal Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global BCG Vaccine for Intradermal Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global BCG Vaccine for Intradermal Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global BCG Vaccine for Intradermal Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas BCG Vaccine for Intradermal Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas BCG Vaccine for Intradermal Injection Sales Market Share by Country (2021-2026)
Table 35. Americas BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas BCG Vaccine for Intradermal Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC BCG Vaccine for Intradermal Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC BCG Vaccine for Intradermal Injection Sales Market Share by Region (2021-2026)
Table 40. APAC BCG Vaccine for Intradermal Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC BCG Vaccine for Intradermal Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe BCG Vaccine for Intradermal Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe BCG Vaccine for Intradermal Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe BCG Vaccine for Intradermal Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa BCG Vaccine for Intradermal Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of BCG Vaccine for Intradermal Injection
Table 52. Key Market Challenges & Risks of BCG Vaccine for Intradermal Injection
Table 53. Key Industry Trends of BCG Vaccine for Intradermal Injection
Table 54. BCG Vaccine for Intradermal Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. BCG Vaccine for Intradermal Injection Distributors List
Table 57. BCG Vaccine for Intradermal Injection Customer List
Table 58. Global BCG Vaccine for Intradermal Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global BCG Vaccine for Intradermal Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas BCG Vaccine for Intradermal Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas BCG Vaccine for Intradermal Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC BCG Vaccine for Intradermal Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC BCG Vaccine for Intradermal Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe BCG Vaccine for Intradermal Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe BCG Vaccine for Intradermal Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global BCG Vaccine for Intradermal Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global BCG Vaccine for Intradermal Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global BCG Vaccine for Intradermal Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global BCG Vaccine for Intradermal Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 74. Merck BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Sanofi Pasteur Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Pasteur BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 79. Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Sanofi Pasteur Main Business
Table 81. Sanofi Pasteur Latest Developments
Table 82. Japan BCG Lab Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Japan BCG Lab BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 84. Japan BCG Lab BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Japan BCG Lab Main Business
Table 86. Japan BCG Lab Latest Developments
Table 87. Shanghai Institute of Biological Products Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 89. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Shanghai Institute of Biological Products Main Business
Table 91. Shanghai Institute of Biological Products Latest Developments
Table 92. Serum Institute of India Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Serum Institute of India BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 94. Serum Institute of India BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Serum Institute of India Main Business
Table 96. Serum Institute of India Latest Developments
Table 97. Intervax Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Intervax BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 99. Intervax BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Intervax Main Business
Table 101. Intervax Latest Developments
Table 102. GSBPL Basic Information, BCG Vaccine for Intradermal Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. GSBPL BCG Vaccine for Intradermal Injection Product Portfolios and Specifications
Table 104. GSBPL BCG Vaccine for Intradermal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. GSBPL Main Business
Table 106. GSBPL Latest Developments
LIST OF FIGURES
Figure 1. Picture of BCG Vaccine for Intradermal Injection
Figure 2. BCG Vaccine for Intradermal Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global BCG Vaccine for Intradermal Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global BCG Vaccine for Intradermal Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. BCG Vaccine for Intradermal Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. BCG Vaccine for Intradermal Injection Sales Market Share by Country/Region (2025)
Figure 10. BCG Vaccine for Intradermal Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of BCG for Immunization
Figure 12. Product Picture of BCG for Therapy
Figure 13. Global BCG Vaccine for Intradermal Injection Sales Market Share by Type in 2026
Figure 14. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2021-2026)
Figure 15. BCG Vaccine for Intradermal Injection Consumed in Hospital
Figure 16. Global BCG Vaccine for Intradermal Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. BCG Vaccine for Intradermal Injection Consumed in Clinic
Figure 18. Global BCG Vaccine for Intradermal Injection Market: Clinic (2021-2026) & (K Units)
Figure 19. BCG Vaccine for Intradermal Injection Consumed in Other
Figure 20. Global BCG Vaccine for Intradermal Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global BCG Vaccine for Intradermal Injection Sale Market Share by Application (2025)
Figure 22. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application in 2026
Figure 23. BCG Vaccine for Intradermal Injection Sales by Company in 2026 (K Units)
Figure 24. Global BCG Vaccine for Intradermal Injection Sales Market Share by Company in 2026
Figure 25. BCG Vaccine for Intradermal Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Company in 2026
Figure 27. Global BCG Vaccine for Intradermal Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas BCG Vaccine for Intradermal Injection Sales 2021-2026 (K Units)
Figure 30. Americas BCG Vaccine for Intradermal Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC BCG Vaccine for Intradermal Injection Sales 2021-2026 (K Units)
Figure 32. APAC BCG Vaccine for Intradermal Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe BCG Vaccine for Intradermal Injection Sales 2021-2026 (K Units)
Figure 34. Europe BCG Vaccine for Intradermal Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa BCG Vaccine for Intradermal Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas BCG Vaccine for Intradermal Injection Sales Market Share by Country in 2026
Figure 38. Americas BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas BCG Vaccine for Intradermal Injection Sales Market Share by Application (2021-2026)
Figure 41. United States BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC BCG Vaccine for Intradermal Injection Sales Market Share by Region in 2026
Figure 46. APAC BCG Vaccine for Intradermal Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC BCG Vaccine for Intradermal Injection Sales Market Share by Application (2021-2026)
Figure 49. China BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe BCG Vaccine for Intradermal Injection Sales Market Share by Country in 2026
Figure 57. Europe BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe BCG Vaccine for Intradermal Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of BCG Vaccine for Intradermal Injection in 2026
Figure 74. Manufacturing Process Analysis of BCG Vaccine for Intradermal Injection
Figure 75. Industry Chain Structure of BCG Vaccine for Intradermal Injection
Figure 76. Channels of Distribution
Figure 77. Global BCG Vaccine for Intradermal Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global BCG Vaccine for Intradermal Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global BCG Vaccine for Intradermal Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global BCG Vaccine for Intradermal Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global BCG Vaccine for Intradermal Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global BCG Vaccine for Intradermal Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of BCG Vaccine for Intradermal Injection
Figure 2. BCG Vaccine for Intradermal Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global BCG Vaccine for Intradermal Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global BCG Vaccine for Intradermal Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. BCG Vaccine for Intradermal Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. BCG Vaccine for Intradermal Injection Sales Market Share by Country/Region (2025)
Figure 10. BCG Vaccine for Intradermal Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of BCG for Immunization
Figure 12. Product Picture of BCG for Therapy
Figure 13. Global BCG Vaccine for Intradermal Injection Sales Market Share by Type in 2026
Figure 14. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2021-2026)
Figure 15. BCG Vaccine for Intradermal Injection Consumed in Hospital
Figure 16. Global BCG Vaccine for Intradermal Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. BCG Vaccine for Intradermal Injection Consumed in Clinic
Figure 18. Global BCG Vaccine for Intradermal Injection Market: Clinic (2021-2026) & (K Units)
Figure 19. BCG Vaccine for Intradermal Injection Consumed in Other
Figure 20. Global BCG Vaccine for Intradermal Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global BCG Vaccine for Intradermal Injection Sale Market Share by Application (2025)
Figure 22. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application in 2026
Figure 23. BCG Vaccine for Intradermal Injection Sales by Company in 2026 (K Units)
Figure 24. Global BCG Vaccine for Intradermal Injection Sales Market Share by Company in 2026
Figure 25. BCG Vaccine for Intradermal Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Company in 2026
Figure 27. Global BCG Vaccine for Intradermal Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas BCG Vaccine for Intradermal Injection Sales 2021-2026 (K Units)
Figure 30. Americas BCG Vaccine for Intradermal Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC BCG Vaccine for Intradermal Injection Sales 2021-2026 (K Units)
Figure 32. APAC BCG Vaccine for Intradermal Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe BCG Vaccine for Intradermal Injection Sales 2021-2026 (K Units)
Figure 34. Europe BCG Vaccine for Intradermal Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa BCG Vaccine for Intradermal Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa BCG Vaccine for Intradermal Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas BCG Vaccine for Intradermal Injection Sales Market Share by Country in 2026
Figure 38. Americas BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas BCG Vaccine for Intradermal Injection Sales Market Share by Application (2021-2026)
Figure 41. United States BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC BCG Vaccine for Intradermal Injection Sales Market Share by Region in 2026
Figure 46. APAC BCG Vaccine for Intradermal Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC BCG Vaccine for Intradermal Injection Sales Market Share by Application (2021-2026)
Figure 49. China BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe BCG Vaccine for Intradermal Injection Sales Market Share by Country in 2026
Figure 57. Europe BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe BCG Vaccine for Intradermal Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa BCG Vaccine for Intradermal Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries BCG Vaccine for Intradermal Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of BCG Vaccine for Intradermal Injection in 2026
Figure 74. Manufacturing Process Analysis of BCG Vaccine for Intradermal Injection
Figure 75. Industry Chain Structure of BCG Vaccine for Intradermal Injection
Figure 76. Channels of Distribution
Figure 77. Global BCG Vaccine for Intradermal Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global BCG Vaccine for Intradermal Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global BCG Vaccine for Intradermal Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global BCG Vaccine for Intradermal Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global BCG Vaccine for Intradermal Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global BCG Vaccine for Intradermal Injection Revenue Market Share Forecast by Application (2027-2032)
